Table 2 MCT4 expression in NSCLC tissues with or without predicted pathogenic mutations.
Patient ID | Histology | P/M | ND gene | Mutation | Amino acid change | Evolutionary conservation | MutPred score | Disease association | Homo/ Heterogen/ Hetero | IHC score |
|---|---|---|---|---|---|---|---|---|---|---|
LuAdBrM5 | Adenocarcinoma | M |  ND1 | T3394C | Y30H | Conserved | 0.783 | LHON/Diabetes/ CPT deficiency/ High altitude adaptation | Homo |  +  +  +  +  |
LuAdBrM8 | Adenocarcinoma | M |  ND1 | T3394C |  Y30H |  Conserved |  0.783 | LHON/Diabetes/ CPT deficiency/ High altitude adaptation | Homo |  +  +  +  |
LuAdBrM13 | Adenocarcinoma | M |  ND1 | T3394C |  Y30H |  Conserved |  0.783 | LHON/Diabetes/ CPT deficiency/ High altitude adaptation | Homo |  +  +  +  |
LgCa196 | Adenocarcinoma | P |  ND1 | C3497T |  A64V |  | 0.413 | LHON | Homo |  +  +  +  |
LuAdBrM2 | Adenocarcinoma | M |  ND1 | C3497T |  A64V |  |  0.413 | LHON | Homo |  +  +  +  +  |
LuPoBrM1 | Adenocarcinoma | M |  ND1 | C3497T |  A64V |  |  0.413 | LHON | Homo |  +  +  +  |
LgCa169 | Squamous cell carcinoma | P |  ND1 | H3709A | A135T | Conserved | 0.774 |  | Heterogen or Hetero |  − and +  +  +  +  |
LuAdBrM1 | Adenocarcinoma | M |  ND5 | C12813A | Y159stop |  |  |  | Heterogen or Hetero |  +  +  +  +  |
LgCa173 | Squamous cell carcinoma | P |  ND5 | G13103A | G256E | Conserved | 0.834 |  | Heterogen or Hetero |  +  +  |
LgCa157 | Squamous cell carcinoma | P |  |  None |  |  |  |  |  |  +  +  +  |
LgCa179 | Adenocarcinoma | P |  |  None |  |  |  |  |  |  +  + (local) |
LgCa183 | Squamous cell carcinoma | P |  |  None |  |  |  |  |  |  +  |
LgCa188 | Squamous cell carcinoma | P |  |  None |  |  |  |  |  |  +  |
LgCa193 | Squamous cell carcinoma | P |  |  None |  |  |  |  |  |  +  |
LgCa202 | Adenocarcinoma | P |  |  None |  |  |  |  |  |  +  |
LgCa175 | Adenocarcinoma | P |  |  None |  |  |  |  |  |  +  |
LgCa195 | Bronchioalveolar carcinoma | P |  |  None |  |  |  |  |  |  +  |